Literature DB >> 29344869

Isolation of Amyloid Plaques and Neurofibrillary Tangles from Archived Alzheimer's Disease Tissue Using Laser-Capture Microdissection for Downstream Proteomics.

Eleanor Drummond1, Shruti Nayak2, Geoffrey Pires3, Beatrix Ueberheide4, Thomas Wisniewski5,6.   

Abstract

Here, we describe a new method that allows localized proteomics of amyloid plaques and neurofibrillary tangles (NFTs), which are the two pathological hallmarks of Alzheimer's disease (AD). Amyloid plaques and NFTs are visualized using immunohistochemistry and microdissected from archived, formalin-fixed paraffin-embedded (FFPE) human tissue samples using laser-capture microdissection. The majority of human tissue specimens are FFPE; hence the use of this type of tissue is a particular advantage of this technique. Microdissected tissue samples are solubilized with formic acid and deparaffinized, reduced, alkylated, proteolytically digested, and desalted. The resulting protein content of plaques and NFTs is determined using label-free quantitative LC-MS. This results in the unbiased and simultaneous quantification of ~900 proteins in plaques and ~500 proteins in NFTs. This approach permits downstream pathway and network analysis, hence providing a comprehensive overview of pathological protein accumulation found in neuropathological features in AD.

Entities:  

Keywords:  Alzheimer’s disease; Amyloid plaques; Formalin-fixed paraffin embedded; Laser-capture microdissection; Mass spectrometry; Neurofibrillary tangles

Mesh:

Year:  2018        PMID: 29344869      PMCID: PMC5811767          DOI: 10.1007/978-1-4939-7558-7_18

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

1.  Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection.

Authors:  Lujian Liao; Dongmei Cheng; Jian Wang; Duc M Duong; Tatyana G Losik; Marla Gearing; Howard D Rees; James J Lah; Allan I Levey; Junmin Peng
Journal:  J Biol Chem       Date:  2004-06-25       Impact factor: 5.157

Review 2.  Toward improving the proteomic analysis of formalin-fixed, paraffin-embedded tissue.

Authors:  Carol B Fowler; Timothy J O'Leary; Jeffrey T Mason
Journal:  Expert Rev Proteomics       Date:  2013-08       Impact factor: 3.940

3.  Direct evidence of phosphorylated neuronal intermediate filament proteins in neurofibrillary tangles (NFTs): phosphoproteomics of Alzheimer's NFTs.

Authors:  Parvathi Rudrabhatla; Howard Jaffe; Harish C Pant
Journal:  FASEB J       Date:  2011-08-09       Impact factor: 5.191

4.  Unrestricted modification search reveals lysine methylation as major modification induced by tissue formalin fixation and paraffin embedding.

Authors:  Ying Zhang; Markus Muller; Bo Xu; Yutaka Yoshida; Oliver Horlacher; Frederic Nikitin; Samuel Garessus; Sameh Magdeldin; Naohiko Kinoshita; Hidehiko Fujinaka; Eishin Yaoita; Miki Hasegawa; Frederique Lisacek; Tadashi Yamamoto
Journal:  Proteomics       Date:  2015-05-03       Impact factor: 3.984

Review 5.  Setting proteins free: progresses and achievements in proteomics of formalin-fixed, paraffin-embedded tissues.

Authors:  Alessandro Tanca; Daniela Pagnozzi; Maria Filippa Addis
Journal:  Proteomics Clin Appl       Date:  2011-12-27       Impact factor: 3.494

6.  Laser capture microdissection of fluorescently labeled amyloid plaques from Alzheimer's disease brain tissue for mass spectrometric analysis.

Authors:  Diana A T Nijholt; Christoph Stingl; Theo M Luider
Journal:  Methods Mol Biol       Date:  2015

Review 7.  Biochemistry and cell biology of tau protein in neurofibrillary degeneration.

Authors:  Eva-Maria Mandelkow; Eckhard Mandelkow
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

8.  Proteomic analysis of neurofibrillary tangles in Alzheimer disease identifies GAPDH as a detergent-insoluble paired helical filament tau binding protein.

Authors:  Qin Wang; Randall L Woltjer; P J Cimino; Catherine Pan; Kathleen S Montine; Jing Zhang; Thomas J Montine
Journal:  FASEB J       Date:  2005-03-03       Impact factor: 5.191

9.  Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips.

Authors:  Juri Rappsilber; Matthias Mann; Yasushi Ishihama
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

10.  Impact of routinely employed procedures for tissue processing on the proteomic analysis of formalin-fixed paraffin-embedded tissue.

Authors:  Peter Bronsert; Juliane Weißer; Martin L Biniossek; Markus Kuehs; Bettina Mayer; Vanessa Drendel; Sylvia Timme; Hasmik Shahinian; Simon Küsters; Ulrich F Wellner; Silke Lassmann; Martin Werner; Oliver Schilling
Journal:  Proteomics Clin Appl       Date:  2014-07-24       Impact factor: 3.494

View more
  12 in total

Review 1.  Fibrinogen alpha amyloidosis: insights from proteomics.

Authors:  Jessica Chapman; Ahmet Dogan
Journal:  Expert Rev Proteomics       Date:  2019-08-28       Impact factor: 3.940

2.  Phosphorylated tau interactome in the human Alzheimer's disease brain.

Authors:  Eleanor Drummond; Geoffrey Pires; Claire MacMurray; Manor Askenazi; Shruti Nayak; Marie Bourdon; Jiri Safar; Beatrix Ueberheide; Thomas Wisniewski
Journal:  Brain       Date:  2020-09-01       Impact factor: 13.501

Review 3.  Deep Profiling of the Aggregated Proteome in Alzheimer's Disease: From Pathology to Disease Mechanisms.

Authors:  Brianna M Lutz; Junmin Peng
Journal:  Proteomes       Date:  2018-11-12

4.  The amyloid plaque proteome in early onset Alzheimer's disease and Down syndrome.

Authors:  Eleanor Drummond; Tomas Kavanagh; Geoffrey Pires; Mitchell Marta-Ariza; Evgeny Kanshin; Shruti Nayak; Arline Faustin; Valentin Berdah; Beatrix Ueberheide; Thomas Wisniewski
Journal:  Acta Neuropathol Commun       Date:  2022-04-13       Impact factor: 7.578

5.  Targeting microglial autophagic degradation of the NLRP3 inflammasome for identification of thonningianin A in Alzheimer's disease.

Authors:  Xiao-Gang Zhou; Wen-Qiao Qiu; Lu Yu; Rong Pan; Jin-Feng Teng; Zhi-Pei Sang; Betty Yuen-Kwan Law; Ya Zhao; Li Zhang; Lu Yan; Yong Tang; Xiao-Lei Sun; Vincent Kam Wai Wong; Chong-Lin Yu; Jian-Ming Wu; Da-Lian Qin; An-Guo Wu
Journal:  Inflamm Regen       Date:  2022-08-03

6.  Proteomic differences in the hippocampus and cortex of epilepsy brain tissue.

Authors:  Geoffrey Pires; Dominique Leitner; Eleanor Drummond; Evgeny Kanshin; Shruti Nayak; Manor Askenazi; Arline Faustin; Daniel Friedman; Ludovic Debure; Beatrix Ueberheide; Thomas Wisniewski; Orrin Devinsky
Journal:  Brain Commun       Date:  2021-03-09

7.  Patterns of Expression of Purinergic Receptor P2RY12, a Putative Marker for Non-Activated Microglia, in Aged and Alzheimer's Disease Brains.

Authors:  Douglas G Walker; Tiffany M Tang; Anarmaa Mendsaikhan; Ikuo Tooyama; Geidy E Serrano; Lucia I Sue; Thomas G Beach; Lih-Fen Lue
Journal:  Int J Mol Sci       Date:  2020-01-20       Impact factor: 5.923

8.  Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer's disease and not in other tauopathies.

Authors:  Geoffrey Pires; Sacha McElligott; Shiron Drusinsky; Glenda Halliday; Marie-Claude Potier; Thomas Wisniewski; Eleanor Drummond
Journal:  Acta Neuropathol Commun       Date:  2019-12-03       Impact factor: 7.801

Review 9.  Proteomics Landscape of Alzheimer's Disease.

Authors:  Ankit P Jain; Gajanan Sathe
Journal:  Proteomes       Date:  2021-03-10

10.  Proteomic differences in hippocampus and cortex of sudden unexplained death in childhood.

Authors:  Dominique F Leitner; Christopher William; Arline Faustin; Manor Askenazi; Evgeny Kanshin; Matija Snuderl; Declan McGuone; Thomas Wisniewski; Beatrix Ueberheide; Laura Gould; Orrin Devinsky
Journal:  Acta Neuropathol       Date:  2022-03-25       Impact factor: 15.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.